A review of analytical methods for the determination of 5-fluorouracil in biological matrices

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Analytical and Bioanalytical Chemistry

• Publication date

  2010-04-11

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/s00216-010-3633-8PMID 20383700
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of Plyometric Training on Swimming Block Start Performance in Adolescents

  2009cited by this paper
• Irinotecan+5-fluorouracil with concomitant pre-operative radiotherapy in locally advanced non-resectable rectal cancer: a phase I/II study

  2008cited by this paper
• Quantitation of 5-fluorouracil (5-FU) in human plasma by liquid chromatography/electrospray ionization tandem mass spectrometry.

  2008cited by this paper
• Hydrophilic interaction liquid chromatography-APCI-mass spectrometry determination of 5-fluorouracil in plasma and tissues.

  2005cited by this paper
• A Simple and Sensitive Fully Validated HPLC-UV Method for the Determination of 5-Fluorouracil and Its Metabolite 5,6-Dihydrofluorouracil in Plasma

  2005cited by this paper
• Sensitive MS/MS-liquid chromatography assay for simultaneous determination of tegafur, 5-fluorouracil and 5-fluorodihydrouracil in plasma.

  2005cited by this paper
• Analysis of 5-fluorouracil in saliva using surface-enhanced Raman spectroscopy

  2005cited by this paper
• Validated liquid chromatographic determination of 5-fluorouracil in human plasma.

  2004cited by this paper
• Prolonged retention of high concentrations of 5-fluorouracil in human and murine tumors as compared with plasma

  2004cited by this paper
• Four decades of continuing innovation with fluorouracil: current and future approaches to fluorouracil chemoradiation therapy.

  2004cited by this paper
• Platinum-based chemotherapy in metastatic breast cancer: current status.

  2004cited by this paper
• Plasma concentrations of 5-fluorouracil and its metabolites in colon cancer patients.

  2004cited by this paper
• Current treatments and future perspectives in colorectal and gastric cancer.

  2003cited by this paper
• 5-Fluorouracil: mechanisms of action and clinical strategies

  2003cited by this paper
• HPLC-UV analysis of 5-fluorouracil and its metabolite dihydrofluorouracil in plasma. An improved method suitable for TDM

  2003cited by this paper
• Sensitive liquid chromatographic assay for the simultaneous determination of 5-fluorouracil and its prodrug, tegafur, in beagle dog plasma.

  2003cited by this paper
• Determination of 5-Fluorouracil and Its Prodrug Tegafur in Plasma and Tissue by High-Performance Liquid Chromatography in a Single Injection: Validation for Application in Clinical Pharmacokinetic Studies

  2003cited by this paper
• Oesophageal cancer: new developments in systemic therapy.

  2003cited by this paper
• Simultaneous HPLC determination of 5-fluorouracil and its metabolites in plasma of cancer patients.

  2002cited by this paper
• An HPLC method for the measurement of 5-fluorouracil in human plasma with a low detection limit and a high extraction yield.

  2002cited by this paper
• Simultaneous determination of flucytosine and fluorouracil in human plasma by high-performance liquid chromatography.

  2001cited by this paper
• 5-Fluorouracil: Forty-Plus and Still Ticking. A Review of its Preclinical and Clinical Development

  2000cited by this paper
• Simple and sensitive determination of 5-fluorouracil in plasma by high-performance liquid chromatography. Application to clinical pharmacokinetic studies.

  1999cited by this paper
• Determination of 5-fluorouracil in microvolumes of human plasma by solvent extraction and high-performance liquid chromatography.

  1999cited by this paper
• Dose monitoring of 5-fluorouracil in patients with colorectal or head and neck cancer--status of the art.

  1999cited by this paper
• Simultaneous determination of 5-fluorouracil and uracil by high-performance liquid chromatography using four serial columns.

  1998cited by this paper
• Derivatization of 5-fluorouracil with 4-bromomethyl-7-methoxycoumarin for determination by liquid chromatography-mass spectrometry

  1998cited by this paper
• Tumor selective delivery of 5-fluorouracil by capecitabine, a new oral fluoropyrimidine carbamate, in human cancer xenografts.

  1998cited by this paper
• High-performance liquid chromatographic assay of 5-fluorouracil in human erythrocytes, plasma and whole blood.

  1997cited by this paper
• Simultaneous gas chromatographic—mass spectrophotometric determination of α-fluoro-β-alanine and 5-fluorouracil in plasma

  1997cited by this paper
• Determination of 5-fluorouracil and its main metabolites in plasma by high-performance liquid chromatography: application to a pharmacokinetic study.

  1997cited by this paper
• Simultaneous determination of 5-fluorouracil and its active metabolites in serum and tissue by high-performance liquid chromatography.

  1997cited by this paper
• Simultaneous gas chromatographic-mass spectrophotometric determination of alpha-fluoro-beta-alanine and 5-fluorouracil in plasma.

  1997cited by this paper
• Simultaneous determination of dihydrofluorouracil and 5-fluorouracil in plasma by high-performance liquid chromatography.

  1997cited by this paper
• Determination of S-1 (combined drug of tegafur, 5-chloro-2,4-dihydroxypyridine and potassium oxonate) and 5-fluorouracil in human plasma and urine using high-performance liquid chromatography and gas chromatography-negative ion chemical ionization mass spectrometry.

  1997cited by this paper
• A Simple Chromatographic Method for the Analysis of Pyrimidines and their Dihydrogenated Metabolites

  1997cited by this paper
• HPLC Analysis and Validation of 5-Fluorouracil and Its Metabolites in Rat Plasma

  1997cited by this paper
• Rapid and sensitive high-performance liquid chromatographic analysis of halogenopyrimidines in plasma.

  1997cited by this paper
• Measurement of 5-fluorouracil in scalp hair: a possible index of patient compliance with oral adjuvant chemotherapy

  1996cited by this paper
• Determination of 5-fluorouracil in human plasma by a simple and sensitive reversed-phase HPLC method.

  1996cited by this paper
• High-performance liquid chromatographic determination of 5-fluorouracil and its prodrugs, tegafur and 4-deoxy-5-fluorouracil, in rat plasma.

  1996cited by this paper
• Measurement of plasma 5-fluorouracil by high-performance liquid chromatography with comparison of results to tissue drug levels observed using in vivo 19F magnetic resonance spectroscopy in patients on a protracted venous infusion with or without interferon-alpha.

  1996cited by this paper
• Simple high-performance liquid chromatographic method for the quantitation of 5-fluorouracil in human plasma.

  1996cited by this paper
• Relationship between 5‐fluorouracil (5‐FU) dose intensity and therapeutic response in patients with advanced colorectal cancer receiving infusional therapy containing 5‐FU

  1996cited by this paper
• HPLC analysis of 5-FU and FdUMP in tissue and serum.

  1995cited by this paper
• Gene transfer into mammalian cells by particle bombardment.

  1994cited by this paper
• A procedure for the determination of 5-fluorouracil in tissue using microbore HPLC and fluorescence detection.

  1994cited by this paper
• Determination of the concentrations of 5-fluorouracil and its metabolites in rabbit plasma and tissues by high-performance liquid chromatography.

  1994cited by this paper
• Determination of leucovorin and 5-fluorouracil in plasma by high-performance liquid chromatography.

  1993cited by this paper
• Determination of 5-fluorouracil and its main metabolites in plasma by high-performance liquid chromatography.

  1992cited by this paper
• Gas chromatographic-mass spectrometric method for routine monitoring of 5-fluorouracil in plasma of patients receiving low-level protracted infusions.

  1992cited by this paper
• Analysis of 5-fluorouracil in plasma and urine by high-performance liquid chromatography.

  1992cited by this paper
• High-performance liquid chromatographic method for the simultaneous measurement of floxuridine and fluorouracil in human body fluids.

  1991cited by this paper
• Highly sensitive method for the determination of 5-fluorouracil in biological samples in the presence of 2'-deoxy-5-fluorouridine by gas chromatography-mass spectrometry.

  1991cited by this paper
• The analysis of 5-fluorouracil in human plasma by gas chromatography-negative ion chemical ionization mass spectrometry (GC-NICIMS) with stable isotope dilution.

  1991cited by this paper
• A simple high pressure liquid chromatographic method for the determination of fluorouracil to monitor patients on regional infusion for hepatic metastases

  1990cited by this paper
• Measurement of 5-fluorouracil and its active metabolites in tissue.

  1990cited by this paper
• Rapid and simple high-performance liquid chromatographic assay for 5'-fluorouracil in plasma for bioavailability studies.

  1990cited by this paper
• High-performance liquid chromatography of 5-fluorouracil after derivatization with 4-bromomethyl-7-methoxycoumarin. Characterization of the derivative and the use of column switching for the improvement of resolution and the enhancement of sensitivity.

  1989cited by this paper
• Analysis of 5-fluorouracil in plasma by precolumn derivatization with 4-bromomethyl-7-methoxycoumarin, followed by multi-dimensional high-performance liquid chromatography.

  1989cited by this paper
• Clinical Pharmacology of 5-Fluorouracil

  1989cited by this paper
• Analysis of 5-flourouracil in plasma by precolumn derivatization with 4-bromomethyl-7-methoxycoumarin, followed by multi-dimensional high-performance liquid chromatography

  1989cited by this paper
• 4-Bromomethyl-6,7-dimethoxycoumarin as a fluorescence reagent for precolumn derivatization of 5-fluorouracil compounds in high-performance liquid chromatography.

  1988cited by this paper
• Pharmacokinetics of 5-fluorouracil assessed with a sensitive mass spectrometric method in patients on a dose escalation schedule.

  1988cited by this paper
• Determination of 5-fluorouracil in plasma and whole blood by ion-pair high-performance liquid chromatography.

  1988cited by this paper
• Determination of 5-fluorouracil in plasma and liver after oral administration of 5'-deoxy-5-fluorouridine using gas chromatography-mass spectrometry.

  1988cited by this paper
• Bioanalysis of fluorouracil applying liquid chromatography and valve switching

  1988cited by this paper
• High-performance liquid chromatographic analysis of fluoropyrimidine nucleosides and fluorouracil in plasma.

  1987cited by this paper
• Stability of 5-fluorouracil in whole blood and plasma.

  1987cited by this paper
• Determination of 5-Fluorouracil and 5-Fluoro-2′-deoxyuridine in Human Serum by High Performance Liquid Chromatography with Fluorescence Detection

  1987cited by this paper
• The Stability of 5,6‐Dihydrofluorouracil in Plasma and the Consequences for Its Analysis

  1987cited by this paper
• Use of 4-bromomethyl-7-methoxycoumarin for derivatization of pyrimidine compounds in serum analysed by high-performance liquid chromatography with fluorimetric detection.

  1986cited by this paper
• Sensitive high-performance liquid chromatographic method for the determination of 5-fluorouracil in plasma.

  1985cited by this paper
• Analysis of 5'-deoxy-5-fluorouridine and 5-fluorouracil in human plasma and urine by high-performance liquid chromatography.

  1985cited by this paper
• Highly sensitive determination of 5-fluorouracil in human plasma by capillary gas chromatography and negative ion chemical ionization mass spectrometry.

  1985cited by this paper
• Gas-liquid chromatographic analysis of fluoropyrimidine nucleosides and fluorouracil in plasma and urine.

  1985cited by this paper
• Fluorescence determination of 5-fluorouracil and 1-(tetrahydro-2-furanyl)-5-fluorouracil in blood serum by high-performance liquid chromatography.

  1984cited by this paper
• Stability of fluorouracil in plastic containers used for continuous infusion at home.

  1984cited by this paper
• Determination of the underivatized antineoplastic drugs CP, 5-FU and somE of their metabolites by capillary gas chromatography combined with electron capture and nitrogen-phosphorous selective detection

  1983cited by this paper
• Simultaneous determination of tegafur and 5-fluorouracil in serum by GLC using nitrogen-sensitive detection.

  1983cited by this paper
• Determination of the underivatized antineoplastic drugs cyclophosphamide and 5-fluorouracil and some of their metabolites by capillary gas chromatography combined with electron-capture and nitrogen-phosphorus selective detection.

  1983cited by this paper
• A gas chromatographic assay for the determination of 5,6-dihydrofluorouracil and 5-fluorouracil in human plasma.

  1983cited by this paper
• Quantitative analysis of 5-fluorouracil and 5,6-dihydrofluorouracil in plasma by gas chromatography mass spectrometry.

  1982cited by this paper
• Rapid catabolism of 5-fluorouracil in freshly isolated rat hepatocytes as analyzed by high performance liquid chromatography.

  1982cited by this paper
• A Rapid High-Performance Liquid Chromatographic Method for Quantitation of 5-Fluorouracil in Plasma after Continuous Intravenous Infusion

  1982cited by this paper
• Spectrophotometric analysis for fluorouracil in biological fluids.

  1981cited by this paper
• Comparative determinations of 5-fluorouracil in plasma using GC/MS and HPLC.

  1981cited by this paper
• Gas chromatographic—mass spectrometric determination of plasma 5-fluorouracil after administration of 1-hexylcarbamoyl-5-fluorouracil to dogs and humans

  1981cited by this paper
• High-pressure liquid chromatographic determination of ftorafur [1-(tetrahydro-2-furanyl)-5-fluorouracil] and GLC-mass spectrometric determination of 5-fluorouracil and uracil in biological materials after oral administration of uracil plus ftorafur.

  1980cited by this paper
• A review of the United States clinical experience of the fluoropyrimidine, ftorafur (NSC-148958).

  1980cited by this paper
• Analysis of fluorouracil in human plasma by combined gas-liquid chromatography mass spectrometry.

  1980cited by this paper
• Simultaneous liquid chromatography of 5-fluorouracil, uridine, hypoxanthine, xanthine, uric acid, allopurinol, and oxipurinol in plasma.

  1980cited by this paper
• Determination of 5-Fluorouracil in Human Plasma by High-Pressure Ion-Exchange Chromatography

  1980cited by this paper
• A sensitive method for determination of 5-fluorouracil and 5-fluoro-2'-deoxyuridine in human plasma by high-pressure liquid chromatography.

  1980cited by this paper
• Determination of 5-fluorouracil and pyrimidine bases in plasma by gas chromatography-chemical ionization-mass fragmentography.

  1980cited by this paper
• Potential clinical applications of a new method for quantitation of plasma levels of 5-fluorouracil and 5-fluorodeoxyuridine.

  1979cited by this paper
• Quantitative gas-liquid chromatographic determination of ftorafur and 5-fluorouracil in biological specimens.

  1979cited by this paper
• Comparison of liquid- and gas-liquid chromatographic assays of 5-fluorouracil in plasma.

  1979cited by this paper
• Gas-liquid chromatography of some alkyl derivatives of 5-fluorouracil.

  1979cited by this paper
• Determination of 5-fluorouracil in plasma by GC/MS using an internal standard. Applications to pharmacokinetics.

  1979cited by this paper

• Selective Gas Chromatography Analysis of 5-Fluorouracil from Serum of Cancer Patients after Chemotherapy by Derivatization

  2025cites this paper
• 5-Fluorouracil Toxicity: Revisiting the Relevance of Pharmacokinetic Parameters

  2025cites this paper
• Synergistic Effect of Nickel Hydroxide/Hexagonal Boron Nitride Hybrid: An Efficient Electrocatalyst for Detecting 5-Fluorouracil in Human Blood Serum.

  2025cites this paper
• A development of sensor based on ZnO@ZIF-8 for detection of 5-Fluorouracil as a liver cancer medicine in serum samples

  2024cites this paper
• Facile electrochemical determination of 5-fluorouracil as an important anti-cancer drug using CeO2–CuO nanocomposite modified carbon paste electrode

  2024cites this paper
• Optimizing cancer patient care with a robust assay for 5-fluorouracil quantification and in-vitro stability in human blood for therapeutic drug monitoring

  2024cites this paper
• Recent advances in electrochemical determination of anticancer drug 5-fluorouracil

  2023cites this paper
• An updated review on properties, nanodelivery systems, and analytical methods for the determination of 5-fluorouracil in pharmaceutical and biological samples.

  2022cites this paper
• Polymer-Coated Polymeric (PCP) Microneedles for Controlled Dermal Delivery of 5-Fluorouracil

  2022cites this paper
• Development of an HPLC-DAD Method for the Extraction and Quantification of 5-Fluorouracil, Uracil, and 5-Fluorodeoxyuridin Monophosphate in Cells and Culture Media of Lactococcus lactis

  2022cites this paper
• GC Determination of Fluorouracil in Serum by Using Hexafluroroacetylacetone as Derivatizing Reagent.

  2022cites this paper
• The Superoxide Dismutase Mimetic M40403, Improves 5-Fluorouracil-induced Small Intestinal Mucositis in a Mouse Model

  2021cites this paper
• Synthesis of nitrogen-doped carbon quantum dots@Fe2O3/multiwall carbon nanotubes ternary nanocomposite for the simultaneous electrochemical detection of 5-fluorouracil, uric acid, and xanthine

  2021cites this paper
• Development of a novel chromatographic method for concurrent determination of 5-fluorouracil and cisplatin: Validation, greenness evaluation, and application on drug-eluting film

  2021cites this paper
• Current status and future outlooks on therapeutic drug monitoring of fluorouracil

  2021cites this paper
• Analytical and bioanalytical HPLC method for simultaneous estimation of 5-fluorouracil and sonidegib.

  2021cites this paper
• Temperature-reversible switched antineoplastic drug 5-fluorouracil electrochemical sensor based on adaptable thermo-sensitive microgel encapsulated PEDOT

  2020cites this paper
• Analytical method development and validation of anticancer agent, 5-fluorouracil, and its metabolites in biological matrices: An updated review

  2020cites this paper
• New reductant-free synthesis of gold nanoparticles-doped chitosan-based semi-IPN nanogel: A robust nanoreactor for exclusively sensitive 5-fluorouracil sensor.

  2020cites this paper
• A simple and efficient sequential electrokinetic and hydrodynamic injections in micellar electrokinetic chromatography method for quantification of anticancer drug 5-fluorouracil and its metabolite in human plasma.

  2020cites this paper
• DNA-Based Nanomedicine with Targeting and Enhancement of Therapeutic Efficacy of Breast Cancer Cells.

  2019cites this paper
• Cytostatic and Antiproliferative Activities of F5 Fraction of Crinum amabile Leaf Chloroform Extract Showed Its Potential as Cancer Chemotherapeutic Agent

  2019cites this paper
• Development and Validation of a New Stability Indicating Reversed-phase High‑Performance Liquid Chromatography Method for the Simultaneous Estimation of Tegafur and Uracil in Capsule Dosage Form

  2018cites this paper
• Therapeutic Drug Monitoring in Oncology: International Association of Therapeutic Drug Monitoring and Clinical Toxicology Recommendations for 5‐Fluorouracil Therapy

  2018cites this paper
• Management of 5-fluorouracil treatment using Therapeutic drug monitoring (TDM)

  2017cites this paper
• A new automated gas chromatography/solid phase microextraction procedure for determining α-fluoro-β-alanine in urine

  2017cites this paper
• Biosensors and nanobiosensors for therapeutic drug and response monitoring.

  2016cites this paper
• Therapeutic drug monitoring of 5-fluorouracil

  2016cites this paper
• A simultaneous determination method for 5-fluorouracil and its metabolites in human plasma with linear range adjusted by in-source collision-induced dissociation using hydrophilic interaction liquid chromatography-electrospray ionization-tandem mass spectrometry.

  2016cites this paper
• Electrochemical Sensor for the Determination of Anticancer Drug 5‐ Fluorouracil at Glucose Modified Electrode

  2016cites this paper
• Rebamipide attenuates 5-Fluorouracil-induced small intestinal mucositis in a mouse model.

  2015cites this paper
• ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF ANTICANCER DRUGS ( IMATINIB AND CABACITABINE ) BY RP-HPLC METHOD

  2015cites this paper
• Development of molecularly imprinted polymer nanoarrays of N-acryloyl-2-mercaptobenzamide on a silver electrode for ultratrace sensing of uracil and 5-fluorouracil.

  2015cites this paper
• A sensitive electrochemical DNA biosensor for antineoplastic drug 5-fluorouracil based on glassy carbon electrode modified with poly(bromocresol purple).

  2015cites this paper
• Thin-Layer Chromatography of Anticancer Drugs

  2013cites this paper
• MSPE/UV for field detection of micropollutants in water

  2013cites this paper
• Individualização Farmacocinética das Doses de 5-Fluoruracil no Câncer Colorretal Pharmacokinetic Individualization of 5-Fluorouracil Doses in Colorectal Cancer Individualización Farmacocinética de las Dosis de 5-Fluorouracil en el Cáncer Colorrectal

  2013cites this paper
• Molecularly imprinted polymer for recognition of 5-fluorouracil by RNA-type nucleobase pairing.

  2013cites this paper
• The Current Status and Future Prospects of Therapeutic Drug Monitoring of Chemotherapy in Jordan

  2012cites this paper
• An immunoassay method for the pharmacokinetics of 5-fluorouracil in patients with gastric cancer administered adjuvant chemotherapy.

  2012cites this paper
• Paper-based microfluidic surface acoustic wave sample delivery and ionization source for rapid and sensitive ambient mass spectrometry.

  2011cites this paper
• Analysis of anticancer drugs: a review.

  2011cites this paper
• USING ULTRAFILTRATION TO FACILITATE SIMULTANEOUS QUANTIFICATION OF 5-FLUOROURACIL IN MOUSE PLASMA AND TISSUES BY HPLC

  2011influential citation